Rep. Buchanan Leads Bipartisan Push to Expand Medicare Coverage for Home IV Treatments
This bill is currently sitting in the House committees on Energy and Commerce and Ways and Means. It has not moved forward since March 2025, which is a period of 15 months. The bill is considered stalled because no action has been taken by these committees.
No action since March 2025
This bill’s path across every version that has carried it.
Reintroduced
Reintroduced from H.R. 4104 (118th), which died when its Congress ended.
H.R. 4104 (118th) →Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Small home infusion therapy companies would see expanded Medicare reimbursement for their services, including pharmacy work like drug preparation and care coordination. The bill also creates a new 50% payment for days when a supplier isn't physically in the patient's home, giving smaller providers a more reliable revenue stream and making it more financially viable to serve Medicare patients in rural or underserved areas.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Bipartisan lawmakers re-introduced the Preserving Patient Access to Home Infusion Act (H.R. 2172) to modernize Medicare's home infusion benefit. The bill aims to remove the physical presence requirement for reimbursement and acknowledge the full scope of professional pharmacist services.
Members of the National Home Infusion Association met with over 130 congressional offices to advocate for H.R. 2172. The legislation would close Medicare coverage gaps by recognizing essential pharmacy professional services and expanding access to IV anti-infective treatments for seniors.
While Congress passed the Joe Fiandra Access to Home Infusion Act to expand access to pump-administered drugs, advocates emphasize that H.R. 2172 remains the 'next step' needed to establish a comprehensive benefit that covers pharmacy services and allows NPs and PAs to manage care plans.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Preserving Patient Access to Home Infusion Act
Analysis generated by AI. Always verify with official sources.